Gastroenterology 2027

Continuing Education

Hero image with GI tract, endoscope, liver

June 14 - 17, 2027

Course Schedule

Gastroenterology 2027 provides a comprehensive update for clinicians who care for patients with GI disorders. It delivers state-of-the-art clinical strategies, updates, and expanded options for treatment and diagnosis, and guidance for complex and unusual cases.

Live Online

This program uses state-of-the-art streaming technology to present sessions online in real time. Participants can attend from any location, and can interact with faculty via live chat.

Additionally, all sessions will be recorded and made available to participants for online viewing for 90 days after the end of the course.

All live streaming and recorded sessions are eligible for AMA PRA Category 1 Credits™ and other relevant credits. (Note: Evaluations must be completed within 60 days of the conclusion of the course to receive CME credit.)

$1,195 Save with early registration

Save $100. To ensure your participation at the lowest possible cost, early registration is strongly recommended.

The above tuition is for physicians. For other healthcare professionals, please see the pricing table.

Fee increases to $1,295 after May 15, 2027

Continuing Education

Earn up to:

» 27.75 AMA PRA Category 1 Credits™

» 27.75 ABIM MOC points

» 27.75 European CME credits (ECMEC^®)

» Commensurate credits through the Royal College of Physicians and Surgeons of Canada

4 Days

This intensive course, which is among the highest-rated Harvard Medical School CME courses, presents the most up-to-date, evidence-based approaches to gastrointestinal and hepatobiliary disorders.

Overview

The Comprehensive 2027 Gastroenterology Update

Gastroenterology 2027 is a live online course, using live streaming, electronic Q&A, and other remote learning technologies.

This program ensures participants are current with state-of-the-art GI strategies and clinical practices. It covers recent advances and their impact on clinical approaches and on patient outcomes. Updates, best practices, and new guidelines are presented by nationally recognized GI experts and master clinicians.

Practical, Results-Driven Education
Highlights of the 2027 program include:

The newest guidelines for the use of biologics in IBD
Therapeutic drug monitoring in IBD treatment
Management of the older adult with IBD
Updated guidelines for treatment of C. difficile infection
Managing GI complications of immunotherapy and anti-neoplastic therapies
Improved management of IBS
Tips for managing fecal incontinence
Management of refractory GERD
Current approaches to diagnosis and management of celiac disease
Optimal surveillance in hereditary GI cancer syndromes
Current treatment of H. pylori
Updated treatment of HBV and HCV
Management of steatotic liver disease (MASLD) in 2027
How to manage cirrhosis and end-stage liver disease
How to improve your adenoma detection rate (ADR)
Steps to ensure delivery of high-quality colonoscopic care
Techniques to effectively control acute GI bleeding
Endoscopic management of obesity
Management of common anorectal disorders
A comprehensive update of national guidelines

As new strategies, guidelines, and diagnostic and treatment options are presented, they are coupled with specific recommendations for incorporating these updates into your day-to-day work.

Education to Optimize Your Patient Outcomes
The evidence-based recommendations provided in this program cover strategies to improve care and outcomes for patients with:

IBD
GI complications of immunotherapy
Microscopic colitis
Steatotic liver disease (MASLD)
Barrett’s esophagus
Eosinophilic esophagitis
C. difficile colitis
H. pylori infection
Alcohol-related liver disease
Autoimmune hepatitis
IBS
Refractory GERD
Acute pancreatitis
Chronic pancreatitis
Celiac disease
GI bleeding
Pancreatic cysts
SIBO

Recent Advances and Innovations
Clinicians can rely on this program for education on:

Biological therapies for IBD: how to choose which agent to start with? How to monitor during treatment? What is the role for therapeutic drug monitoring? When to switch? What new agents are now available? What agents are on the horizon?
GI complications of immunotherapy — a common and heterogeneous disorder: how to approach and treat effectively?
Eosinophilic esophagitis: how to decide between drug therapy and dietary therapy?
The stool microbiome: understanding the science behind clinical applications
Celiac disease: making sense of the multiple serologic tests—new therapeutic strategies are on the horizon
Adenoma detection rates: critical to measure and how to incorporate strategies, including AI, to increase your rate
Endoscopic approaches to managing obesity
Updated treatments for HBV and HCV
Optimizing management of alcohol-associated liver disease and MASLD

This program also offers a glimpse into the future of gastroenterology with engaging lectures given by world-renowned experts on inspiring and cutting-edge topics.

In addition to being live streamed, all sessions will be recorded and placed in the online course library, enabling registrants to view them at their convenience. Recordings will be available for viewing for 90 days after the conclusion of the course. All live streaming and recorded sessions are eligible for AMA PRA Category 1 Credits™ and other relevant credits. (Note: Evaluations must be completed within 60 days of the conclusion of the course to receive CME credit.)

Developed and Offered By:

Continuing Education courses are developed by faculty from Harvard Medical School's teaching hospitals and accredited by Harvard Medical School. This course is offered by Mass General Brigham and Beth Israel Deaconess Medical Center.

Schedule

This program is among the highest-rated Harvard Medical School CME courses.

All schedule times are Eastern Daylight Time.

Please note that program changes / substitutions may be made without notice.

View and Print Full Schedule

Monday, June 14, 2027

Day 1

Monday, June 14, 2027

Tuesday, June 15, 2027

Day 2

Tuesday, June 15, 2027

Wednesday, June 16, 2027

Day 3

Wednesday, June 16, 2027

Thursday, June 17, 2027

Day 4

Thursday, June 17, 2027

Optimized for Distance Learning

In addition to being live streamed, all sessions and Q & A discussions will be recorded and made available to participants for online viewing for 90 days after the end of the course. This on-demand archive will permit those in different time zones or who have scheduling conflicts to view all sessions that are important to them. In addition, participants can review sessions to reinforce key learning points.

Learning Objectives

Upon completion of this course, participants will be able to:

Interpret major advances in the field of gastroenterology
Incorporate the most up-to-date diagnostic approaches to GI disorders
Identify therapeutic options for GI disorders in an evidence-based manner
Manage patients with both common and rare GI disorders using established guidelines

Hear from Our Participants

What a superb course! I really appreciated the question /answer format as well as the use of cases. Many thanks to all of you!

I found all of the information provided to be educational and applicable to practice.

Excellent course! Great updates and tips. A game changer.

I have updated my practice of surveillance in GI cancer syndromes; treatment of colitis due to immunotherapy; and understanding the role of anti-DGP in the diagnosis of celiac disease.

To read more comments, click here.

Faculty

Course Directors

Daniel C. Chung

Professor of Medicine, Harvard Medical School
Division of Gastroenterology, Massachusetts General Hospital

Nezam Afdhal

Professor of Medicine, Harvard Medical School
Chief, Division of Gastroenterology, Beth Israel Deaconess Medical Center

Raymond Chung

Professor of Medicine, Harvard Medical School
Chief, Division of Gastroenterology, Hepatology & Endoscopy, Mass General Brigham Academic Medical Centers
Zhou Family Endowed Chair in Gastroenterology, Massachusetts General Hospital

Harvard Medical School Faculty

Jessica R. Allegretti, MD, MPH, Associate Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Mass General Brigham

Ashwin N. Ananthakrishnan, MD, MPH, Associate Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Mass General Brigham

Karin L. Andersson, MD, MPH, Assistant Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Mass General Brigham

Tyler Berzin, MD, Associate Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center

Alan Bonder, MD, Associate Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center

Kristin Burke, MD, MPH, Assistant Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Mass General Brigham

Andrew T. Chan, MD, MPH, Daniel K. Podolsky Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Mass General Brigham

Walter Chan, MD, MPH, Associate Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Mass General Brigham

Adam S. Cheifetz, MD, Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center

Daniel C. Chung, MD, Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Mass General Brigham

Kathleen E. Corey, MD, Associate Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Mass General Brigham

Michael P. Curry, MD, Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center

Michael Dougan, MD, PhD, Associate Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Mass General Brigham

Carlos Fernandez-del Castillo, MD, Professor of Surgery, Harvard Medical School; General and Gastrointestinal Surgery, Department of Surgery, Mass General Brigham

Alexander Goldowsky, MD, Assistant Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center

Shilpa Grover, MBBS, MPH, Associate Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Mass General Brigham

Douglas A. Horst, MD, Assistant Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center

Kunal Jajoo, MD, Assistant Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Mass General Brigham

David X. Jin, MD, MPH, Assistant Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Mass General Brigham

Ciaran P. Kelly, MD, Professor of Medicine, Harvard Medical School; Medical Director, Celiac Center, Beth Israel Deaconess Medical Center

Hamed Khalili, MD, MPH, Associate Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Mass General Brigham

Bharati D. Kochar, MD, MS, Assistant Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Mass General Brigham

Joshua R. Korzenik, MD, Associate Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Mass General Brigham

Kumar Krishnan, MD, Assistant Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Mass General Brigham

Michelle Lai, MD, Associate Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center

Linda Lee, MD, Associate Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Mass General Brigham

Ramona Lim, MD, Instructor in Medicine, Harvard Medical School; Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Mass General Brigham

Judy Nee, MD, Assistant Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center

Norman S. Nishioka, MD, Associate Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Mass General Brigham

Trisha Pasricha, MD, Assistant Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center

Douglas K. Pleskow, MD, Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center

Daniel S. Pratt, MD, Assistant Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Mass General Brigham

Loren G. Rabinowitz, MD, Instructor of Medicine, Harvard Medical School; Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center

Chethan Ramprasad, MD, Instructor of Medicine, Harvard Medical School; Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center

Vikram V. Rangan, MD, Assistant Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center

Anna E. Rutherford, MD, MPH, Assistant Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Mass General Brigham

Mandeep S. Sawhney, MD, Associate Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center

Sunil Sheth, MD, Associate Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center

Kyle D. Staller, MD, Associate Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Mass General Brigham

Gyongyi Szabo, MD, PhD, Professor of Medicine, Harvard Medical School; Chief Academic Officer, Beth Israel Deaconess Medical Center

Christopher C. Thompson, MD, Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Mass General Brigham

Ramnik J. Xavier, MD, Kurt J. Isselbacher Professor of Medicine, Harvard Medical School; Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Mass General Brigham

Samantha Zullow, MD, Instructor of Medicine, Harvard Medical School; Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center

Course Fees

Registration Details

Registrations for Harvard Medical School CME programs are made via our secure online registration system. At the end of the registration process, a $10 non-refundable processing fee will be added to your registration.

Upon receipt of your paid registration, an email confirmation will be sent to you. Be sure to include an email address that you check frequently. Your email address is used for critical information, including registration confirmation, evaluation, and certificate.

Please review the cancellation policy.

Early Registration Deadline: May 15, 2027

Role	Course Fee	Early Registration Course Fee
Physician (MD/DO)	$1,295	$1,195
Nurse (RN/APRN)	$1,195	$1,095
PA	$1,195	$1,095
Resident / Fellow	$895	$795
Allied Health Professional / Other	$1,195	$1,095

All registrants of Gastroenterology 2027 will receive an electronic syllabus.

All sessions will be recorded as they are live streamed and placed in the online course video library, so that registrants can review them at their convenience. The video library will be available for 90 days after the conclusion of the course.

Click Here to Register

Accreditation

In support of improving patient care, Harvard Medical School is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

In Person, Hybrid, or Live Online (Virtual) accredited activities: These activities are accredited as Live or Blended/Other activities. To receive CME/CE credit, learners are required to complete the course evaluation. Once the evaluation is complete, you will be able to claim your credit and download your certificate. All evaluations and credit claims must be completed within 60 days of the course end date.

Online; Self Paced (On Demand) accredited activities: These activities are accredited as Enduring activities for three years. To receive CME/CE credit, learners must pass the course post-test and complete the course evaluation in order to claim credit before the final day of the accreditation period. Learners have access to the course for 60 days after the accreditation period has expired.

Physicians

Badge for Jointly Accredited Provider with Commendation Interprofessional Continuing Education

The Harvard Medical School designates this live activity for a maximum of 27.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 27.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Nurse Practitioners and Registered Nurses

For the purpose of recertification, the American Academy of Nurse Practitioners Certification Board and American Nurses Credentialing Center accept AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME (Accreditation Council for Continuing Medical Education). We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.

Physician Assistants

The National Commission on Certification of Physician Assistants (NCCPA) states that AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification. We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.

Royal College of Physicians and Surgeons of Canada (RCPSC)

The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.

Union of European Medical Specialists

The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialists (UEMS). Additional information regarding this agreement may be found on the Union of European Medical Specialists website.

Competencies

ABMS/ACGME Competencies

This course is designed to meet the following American Board of Medical Specialties (ABMS) / Accreditation Council for Graduate Medical Educational (ACGME) competencies:

Medical Knowledge

IOM Competencies

This course is designed to meet the following Institute of Medicine Core Competencies:

Employ Evidence-Based Practice

Disclaimer & Disclosure

Disclaimer Policy

CME activities accredited by Harvard Medical School are offered solely for educational purposes and do not constitute any form of certification of competency. Practitioners should always consult additional sources of information and exercise their best professional judgment before making clinical decisions of any kind.

Note: AMA PRA Category 1 Credit™ is calculated based on submission of a preliminary agenda and may be subject to change.

Disclosure

In accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council for Continuing Medical Education (ACCME), course planners, speakers, and content reviewers have been asked to disclose any relationships they have to companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. In addition, faculty have been asked to list any off-label uses of pharmaceuticals and/or devices for investigational or non-FDA approved purposes that they plan to discuss.

Registration for courses managed by Harvard Medical School can only be completed through Harvard Medical School’s official registration portal: cmeregistration.hms.harvard.edu. Attendee registrations made through any other sites cannot be honored and will not be refunded. Please report any unauthorized websites or solicitations for registrations.

In order to comply with applicable U.S. export control and sanctions regulations, Harvard Medical School prohibits access to and use of Harvard Medical School educational offerings, programs and resources to individuals from certain sanctioned regions or who are otherwise subject to U.S. government sanctions, unless appropriate authorization is in place.

Program Topics

Clinical Practice

Gastroenterology 2027

On This Page

Overview

The Comprehensive 2027 Gastroenterology Update

Developed and Offered By:

Who Should Participate

Schedule

Monday, June 14, 2027

Welcome

Which Initial Therapy to Choose in IBD?

Therapeutic Drug Monitoring in IBD

Putting It Together: Illustrative IBD Case Presentations

Panel Q&A

Management of the Older Adult with IBD

IBD in Pregnancy

Cancer Screening and Health Maintenance in the IBD Patient

New Insights into the Biology of IBD and Therapeutic Targets

Panel Q&A

How to Manage Microscopic Colitis

GI Complications of Immunotherapy

GI Complications of Antineoplastic Therapy

Panel Q&A

High-Risk Cancer Surveillance for GI Cancer Syndromes

CRC Screening and How to Improve Your ADR

Beyond Screening: What to Recommend to Reduce Colorectal Cancer Risk

Panel Q&A

Tuesday, June 15, 2027

Barrett's Esophagus: Whom and How to Treat?

Esophageal Motility Disorders Made Easy

Management of Refractory GERD

Panel Q&A

Comprehensive Approach to Eosinophilic Esophagitis

Celiac Disease and Gluten Sensitivity: 2027 Practitioner Updates

Panel Q&A

Making the Diagnosis of IBS

Modern Strategies to Treat IBS

Tips to Managing Fecal Incontinence

Panel Q&A

Optimizing the Management of Gastroparesis

How to Evaluate Small Intestinal Bacterial Overgrowth

Practical Management of Common Anorectal Disorders

Panel Q&A

Wednesday, June 16, 2027

Cholestatic Liver Diseases: What's New in PBC and PSC

Update on Autoimmune Hepatitis

Current Approaches to the Treatment of HBV and HCV

Panel Q&A

Alcohol-Associated Liver Disease

The Management of MASLD

Panel Q&A

How to Workup a Liver Lesion

Diagnosis and Routine Management of Cirrhosis

Managing Advanced Liver Disease

Panel Q&A

Best Management Strategies in Acute Pancreatitis

Updates in Chronic Pancreatitis

Controversies in the Management of Cystic Lesions of the Pancreas

Panel Q&A

Thursday, June 17, 2027

Tips to Removing the Difficult Colon Polyp

Quality in Colonoscopy: What to Measure and Why It Matters

Advances in Endoscopic Surgery for Foregut Disorders

Panel Q&A

Endoscopy and the Anticoagulated Patient

Acute GI Bleeding and Other GI Emergencies

Endoscopic Approaches to Manage Obesity

Panel Q&A

What's New in C. difficile Colitis

New Insights into the Gut Microbiome and Disease

Current Approach to Diagnosis and Treatment of Helicobacter pylori

GI Cases to Remember

Panel Q&A

Optimized for Distance Learning

Learning Objectives

Hear from Our Participants

Faculty

Course Directors

Daniel C. Chung

Nezam Afdhal

Raymond Chung